As the MvPI is an important programme for reporting adverse events, coordinated analysis, etc related to medical devices, including in-vitro diagnostic devices, it is suggested that all licence holders should also use the MvPI platform for reporting any adverse events/serious adverse events associated with the devices to enhance the procedure for identifying risks associated with medical devices.
CDSCO urges taking appropriate action for timely reporting of medical devices adverse events to MvPl
